• Skip to main content
  • Skip to footer

Life Sciences British Columbia

  • Members Area |
  • Contact Us
  • SearchSearch
  • About
    • Board of Directors
    • Management
    • Vision & Mission
    • LSBC Hall of Fame
  • Awards
  • Membership
    • Sponsors
    • Members Directory
    • Members Area
    • Membership Benefits
    • Membership Discounts
    • Members Services
    • Members Map
    • Become a Member
  • Events
    • Calendar
    • Webinars
    • Past Events
      • 2023 Events
      • 2022 Events
      • 2021 Events
      • 2020 Events
      • 2019 Events
      • 2018 Events
  • News
    • All News
    • Member News
    • Industry News
    • LSBC in The News
    • Publications
    • BC Labour Market Study
  • Resources
    • All Resources
    • Grants and Funding
      • Funding Competitions
      • Wage Subsidies
    • Academic Institutions
    • Government
      • Federal
      • Provincial and Municipal
    • Association Partners
    • Programs
    • Volunteering
  • Jobs
    • Job Board
    • Post a Job
    • Career Events
  • Contact Us
  • Login

Merck Canada Inc.

Member Profile

For more than 125 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases – as we aspire to be the premier research-intensive biopharmaceutical company in the world.

Sector
Global Pharmaceutical Corporations
Area of Expertise
  • Bioinformatics
  • Bioprocessing
  • Bioproducts
  • Drug Delivery
  • Drug Discovery
  • Infectious Diseases
  • Inflammatory Diseases
  • Manufacturer
  • Oncology
  • Product Development
  • Therapeutics
  • Vaccines
  • Wellness solutions
Company Stage Commercial Stage, Private Company

Member Profile

Global Pharmaceutical Corporations

Merck Canada Inc.

Gold Sponsor

Merck Canada Inc logo
  • Website www.merck.ca
  • Phone +1 (514) 428 8600
  • Address
    16750 Trans-Canada Hwy.
    Kirkland, QC
    H9H 4M7
  • Leadership Contact
    Anna Van Acker, President & Managing Director
    Follow us:
  • Twitter
  • Facebook
  • LinkedIn
  • Instagram
  • News
  • Jobs

March 10, 2023

KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survival Versus Chemotherapy Alone as First-Line Treatment for Advanced Malignant Pleural Mesothelioma

October 10, 2022

Merck Recognized on Fortune’s 2022 Change the World List for Expanding Access to HPV Vaccines

September 27, 2022

Merck’s KEYTRUDA® (pembrolizumab) Receives Four New Approvals in Japan, Including in High-Risk Early-Stage Triple-Negative Breast Cancer (TNBC)

August 29, 2022

Merck to Present New Data at ESMO 2022 Congress From Its Broad Oncology Portfolio and Promising Pipeline, Demonstrating Commitment to Improving Long-Term Survival in Multiple Types of Cancer

August 16, 2022

FDA Accepts Submission of Supplemental New Drug Application for LYNPARZA® (olaparib) in Combination With Abiraterone and Prednisone or Prednisolone for Patients With Metastatic Castration-Resistant Prostate Cancer and Grants Priority Review

No current content.

  • Twitter
  • Linkedin
Tweets by Merck Canada Inc.
Connect with us LinkedIn

© 2023 Life Sciences BC  |  Privacy Policy

  • Current Jobs
  • Event Calendar
  • All News
  • Member Directory
    Connect with us
  • LinkedIn
  • Twitter
  • Facebook
  • Instagram
Contact Us